|
|
 Previous Article | Table of Contents | Next Article 
Limitations of Magnetic Resonance Imaging in Measurement of Hepatic Iron
Emanuele Angelucci,
Andrea Giovagnoni,
Gianluca Valeri,
Enrico Paci,
Marta Ripalti,
Pietro Muretto,
Christine McLaren,
Gary M. Brittenham, and
Guido Lucarelli
From the Divisione Ematologica e Centro Trapianto Midollo Osseo di Muraglia, Azienda Ospedale di Pesaro, Pesaro, Italy; Istituto di Radiologia Universita' degli Studi di Ancona, Ancona, Italy; Servizio Anatomia Patologica, Azienda Ospedale di Pesaro, Pesaro, Italy; Department of Mathematics, Moorhead State University, Moorhead, MN; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.
To evaluate the usefulness of magnetic resonance imaging for the quantitative determination of hepatic iron, we examined 43 patients with thalassemia major and assessed the influence of pathologic changes in the liver on the precision of estimates of the hepatic iron concentration. Tissue signal intensities were measured from magnetic resonance T1-weighted images derived from gradient-echo (GE) pulse sequences and the ratio of the signal intensity of liver to muscle calculated. By excluding patients (n = 9) having a signal intensity ratio (SIR) less than or equal to 0.2, a linear relationship with hepatic iron was found and subsequent analyses were limited to these 34 patients. In 27 patients with hepatic fibrosis, an overall correlation of -0.848 was found between hepatic iron and SIR. By contrast, in the seven patients with no fibrosis, the correlation coefficient (-0.993) was significantly greater (P < .0001). Despite the differences in correlation, the regression line between hepatic iron and SIR for the patients with no fibrosis did not differ significantly with respect to either slope or intercept from that of the patients with fibrosis. Thus, the presence of fibrosis did not seem to affect the pattern of the relationship between hepatic iron and the SIR, but rather to increase the variability of the relationship. Clinically, the presence of fibrosis makes estimates of hepatic iron derived from magnetic resonance imaging so variable as to be of little practical use in the management of transfusional iron overload.
Blood, Vol. 90 No. 12 (December 15), 1997:
pp. 4736-4742
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. Angelucci, G. Barosi, C. Camaschella, M. D. Cappellini, M. Cazzola, R. Galanello, M. Marchetti, A. Piga, and S. Tura
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
Haematologica,
May 1, 2008;
93(5):
741 - 752.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Wood, C. Enriquez, N. Ghugre, J. M. Tyzka, S. Carson, M. D. Nelson, and T. D. Coates
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
Blood,
August 15, 2005;
106(4):
1460 - 1465.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Jensen, F. T. Jensen, T. Christensen, H. Eiskjaer, U. Baandrup, and J. L. Nielsen
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool
Blood,
June 1, 2003;
101(11):
4632 - 4639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Brittenham and D. G. Badman
Noninvasive measurement of iron: report of an NIDDK workshop
Blood,
January 1, 2003;
101(1):
15 - 19.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Kushner, J. P. Porter, and N. F. Olivieri
Secondary Iron Overload
Hematology,
January 1, 2001;
2001(1):
47 - 61.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. L. Bonkovsky, A. Davidoff, D. D. Stark, M. Kami, T. Hamaki, Y. Kishi, E. Angelucci, G. M. Brittenham, and G. Lucarelli
Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major
N. Engl. J. Med.,
November 30, 2000;
343(22):
1656 - 1657.
[Full Text]
|
|
|
|
|
|
|
F. E. Chen, C. Ooi, S. Y. Ha, B. M.Y. Cheung, D. Todd, R. Liang, T. K. Chan, and V. Chan
Genetic and Clinical Features of Hemoglobin H Disease in Chinese Patients
N. Engl. J. Med.,
August 24, 2000;
343(8):
544 - 550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Angelucci, G. M. Brittenham, C. E. McLaren, M. Ripalti, D. Baronciani, C. Giardini, M. Galimberti, P. Polchi, and G. Lucarelli
Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major
N. Engl. J. Med.,
August 3, 2000;
343(5):
327 - 331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Sparacia, A. Iaia, A. Banco, P. D'Angelo, and R. Lagalla
Transfusional Hemochromatosis: Quantitative Relation of MR Imaging Pituitary Signal Intensity Reduction to Hypogonadotropic Hypogonadism
Radiology,
June 1, 2000;
215(3):
818 - 823.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N. F. Olivieri
The {beta}-Thalassemias
N. Engl. J. Med.,
July 8, 1999;
341(2):
99 - 109.
[Full Text]
[PDF]
|
|
|
| |
